ZA964392B - P62 its variants nucleic acid sequences and their uses - Google Patents

P62 its variants nucleic acid sequences and their uses

Info

Publication number
ZA964392B
ZA964392B ZA964392A ZA964392A ZA964392B ZA 964392 B ZA964392 B ZA 964392B ZA 964392 A ZA964392 A ZA 964392A ZA 964392 A ZA964392 A ZA 964392A ZA 964392 B ZA964392 B ZA 964392B
Authority
ZA
South Africa
Prior art keywords
nucleic acid
acid sequences
variants nucleic
variants
sequences
Prior art date
Application number
ZA964392A
Other languages
English (en)
Inventor
Fabien Schweighoffer
Bruno Tocque
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA964392B publication Critical patent/ZA964392B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA964392A 1995-06-01 1996-05-29 P62 its variants nucleic acid sequences and their uses ZA964392B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9506533A FR2734826B1 (fr) 1995-06-01 1995-06-01 Deltap62, ses variants, sequences nucleiques et leurs utilisations

Publications (1)

Publication Number Publication Date
ZA964392B true ZA964392B (en) 1996-12-09

Family

ID=9479588

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA964392A ZA964392B (en) 1995-06-01 1996-05-29 P62 its variants nucleic acid sequences and their uses

Country Status (15)

Country Link
US (1) US6544948B1 (xx)
EP (1) EP0828832A2 (xx)
JP (1) JPH11506325A (xx)
KR (1) KR19990022193A (xx)
AU (1) AU718889B2 (xx)
BR (1) BR9608632A (xx)
CA (1) CA2219861A1 (xx)
CZ (1) CZ291533B6 (xx)
FR (1) FR2734826B1 (xx)
HU (1) HUP9901346A3 (xx)
IL (1) IL118493A0 (xx)
NO (1) NO975409L (xx)
SK (1) SK283071B6 (xx)
WO (1) WO1996038556A2 (xx)
ZA (1) ZA964392B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2493300A (en) * 1999-01-06 2000-07-24 Regents Of The University Of California, The Modulation of hiv replication using sam68
WO2003012134A2 (en) * 2001-07-30 2003-02-13 Jacques Brown Paget disease of bone
CA2844283C (en) * 2011-08-08 2024-06-04 Curelab Oncology, Inc. Methods and compositions relating to p62 for the treatment and prophylaxis of cancer
WO2021231652A1 (en) * 2020-05-14 2021-11-18 Curelab Oncology, Inc. Using the p62 plasmid to treat or reduce the severity of coronavirus infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610276A (en) * 1991-05-17 1997-03-11 Chiron Corporation Polypeptides and antibodies derived from GAP associated protein, p62
HU216871B (hu) * 1993-07-13 1999-09-28 Rhone-Poulenc Rorer S.A. Defektív adenovírusvektorok és génterápiai alkalmazásuk

Also Published As

Publication number Publication date
AU6129196A (en) 1996-12-18
FR2734826A1 (fr) 1996-12-06
AU718889B2 (en) 2000-04-20
JPH11506325A (ja) 1999-06-08
MX9708877A (es) 1998-03-31
SK283071B6 (sk) 2003-02-04
HUP9901346A3 (en) 2000-10-30
KR19990022193A (ko) 1999-03-25
NO975409D0 (no) 1997-11-25
IL118493A0 (en) 1996-09-12
US6544948B1 (en) 2003-04-08
EP0828832A2 (fr) 1998-03-18
CZ291533B6 (cs) 2003-03-12
NO975409L (no) 1997-11-25
CA2219861A1 (fr) 1996-12-05
WO1996038556A3 (fr) 1997-01-09
SK161397A3 (en) 1998-07-08
WO1996038556A2 (fr) 1996-12-05
BR9608632A (pt) 1999-05-04
HUP9901346A2 (hu) 1999-08-30
CZ375997A3 (cs) 1998-02-18
FR2734826B1 (fr) 1997-07-04

Similar Documents

Publication Publication Date Title
HK1014561A1 (en) Modified nucleic acid probes
GB2314508B (en) Diamide-dicarboxylic acid microspheres
IL105874A0 (en) New dna sequences and their uses
AU6623896A (en) Detection of nucleic acids and nucleic acid units
IL136349A0 (en) Virulence-associated nucleic acid sequences and uses thereof
ZA965342B (en) Beta-xylosidase nucleotide sequence encoding it and use thereof
NZ286622A (en) Fluorophenylalkenylcarboxylic acid guanidides
AU6057296A (en) DNA sequencing and DNA terminators
GB9516059D0 (en) Novel genes and proteins
GB9502468D0 (en) DNA Sequence
AU3979395A (en) DNA sequences and their use
GB9526218D0 (en) DNA Sequences
GB9517914D0 (en) Identification of bases in nucleic acid sequences
IL105894A0 (en) Detection of nucleic acid sequences
AU7016096A (en) Nucleic acid clamps
ZA964392B (en) P62 its variants nucleic acid sequences and their uses
GB9410170D0 (en) Nucleic acid
AU6483896A (en) Nucleotide and amino acid sequence and uses thereof
IL111857A0 (en) Detection of nucleic acid sequences
AU4931196A (en) Nucleic acid polyester polyamides
PL324340A1 (en) Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids
GB9210916D0 (en) Nucleic acid quantification
AU5539096A (en) Nucleic acid sequencing
GB9512092D0 (en) Proteins and nucleic acids
GB9322722D0 (en) Immobilising nucleic acid sequences